-
Cinda Biotech obtains exclusive license for ROS1/NTRK inhibitors from Baoyuan Pharmaceuticals in Greater China
Time of Update: 2021-06-04
The trial includes a phase 2 clinical trial in China with indications for NTRK-positive solid tumors, and a phase 2 clinical trial with indications for first-line and second-line ROS1-positive non-small cell lung cancer in the world.
-
Pharmacy filing is not active?
Time of Update: 2021-06-04
Therefore, it is very necessary for MAH (Holder of Drug Marketing Authorization) to hire a large number of medical representatives to conduct academic promotion to doctors and patients, and to analyze the product's characteristics, advantages, usage and dosage, indications, contraindications, precautions for use, and adverse reactions.
-
What is the difference between the one-shot, two-shot, and three-shot COVID-19 vaccines?
Time of Update: 2021-06-04
The new crown vaccines currently used in my country for the one-shot, two-shot or three-shot immunization program are the best immunization programs determined based on the technical characteristics of each vaccine and the results of clinical trials.
-
Hausen "Erlotinib Hydrochloride Tablets" Approved for Listing
Time of Update: 2021-06-04
On May 31, Hausen's "Erlotinib Hydrochloride Tablets" was approved by the National Medical Products Administration (NMPA), becoming the second domestic generic drug of this variety.
-
10 gynecological Chinese patent medicine hospitals are selling big!
Time of Update: 2021-06-04
2020 Top 10 Chinese Patented Gynecological Products in Public Medical Institutions in China Source: Terminal competition landscape of China's public medical institutions Among the TOP10 products, 9 are exclusive, involving 8 companies including Zhuzhou Qianjin Pharmaceutical, Shandong Buchang Shenzhou Pharmaceutical, Jiangsu Kangyuan Pharmaceutical, etc.
-
Yangtze River's Class 1 new drug "Levoornidazole Disodium Phosphate for Injection" was approved for marketing
Time of Update: 2021-06-04
In addition, levornidazole disodium phosphate has the following advantages over the clinically used ornidazole sodium chloride injection and levornidazole sodium chloride injection: 1) the lipophilicity is enhanced, compared with ornidazole and Levoornidazole has significantly reduced toxicity and prolonged drug metabolism; 2) Impurity studies have shown that it will not produce toxic degradation product 2-methyl-5nitroimidazole; 3) The pH value when it is prepared into an intravenous preparation Around 5.
-
500 million antidepressants!
Time of Update: 2021-06-04
com, May 31, on May 27, the official website of the State Food and Drug Administration showed that Shanghai Shangyao Zhongxi Pharmaceutical’s duloxetine hydrochloride enteric-coated tablets was approved as a supplementary application, and it was the first company to have reviewed the product.
-
Tianyao: Methylprednisolone sodium succinate for injection passed the consistency evaluation
Time of Update: 2021-06-04
Jinyao Pharmaceutical's methylprednisolone sodium succinate for injection obtained drug registration approval issued by the National Medical Products Administration in November 2012.
In March 2019, Jinyao Pharmaceutical submitted a supplementary application for consistency evaluation to the Drug Evaluation Center of the National Medical Products Administration and was accepted.
-
Health Commission: 23 new confirmed cases and 11 local cases
Time of Update: 2021-06-04
The latest situation of the novel coronavirus pneumonia epidemic as of 24:00 on May 31 The latest situation of the novel coronavirus pneumonia epidemic as of 24:00 on May 31 The lat
-
The liberalization of the three-child policy has far-reaching impact in these medical fields...
Time of Update: 2021-06-04
In this regard, since the liberalization of the two-child policy, the National Health Statistics Yearbook data has changed significantly: In 2017, the number of outpatient visits in general hospitals in China was 240 million, the proportion of pediatric outpatients in general outpatient visits increased from 8.
-
Will the new crown vaccine be charged?
Time of Update: 2021-06-04
National Health Commission: Do not believe or spread rumors Cui Gang, the second-level inspector of the CDC of the National Health Commission, said on the 31st that according to the needs of my country’s new crown pneumonia epidemic prevention and control, combined with the actual supply and work arrangements, my country is currently advancing in accordance with the echelon, highlighting key points, informed consent, voluntary and free vaccination.
-
The State Food and Drug Administration approves the marketing of Contizolamide tablets
Time of Update: 2021-06-04
It is used to treat Staphylococcus aureus (methicillin sensitive and resistant strains), Streptococcus pyogenes or Streptococcus agalactiae that are sensitive to contizolamide Complicated skin and soft tissue infections caused by.
. The launch of this variety provides a new treatment option for patients with complicated skin and soft tissue infections.
-
WHO puts China's Kexing Covid-19 vaccine on the "emergency use list"
Time of Update: 2021-06-04
WHO puts China's Kexing Covid-19 vaccine on the "emergency use list" WHO puts China's Kexing Covid-19 vaccine on the "Emergency Use List" WHO puts China's Kexing Covid-19 vaccine on
-
Avoid stigmatization WHO uses Greek letters to name mutated new coronavirus
Time of Update: 2021-06-04
Avoid stigmatization WHO uses Greek letters to name mutated new coronavirus Avoid stigmatization WHO uses Greek letters to name mutated new coronavirus avoid stigmatization WHO uses Greek letters to name mutated new coronavirus China News Service, June 1 reported that on May 31, the World Health Organization (WHO) announced that it would use Greek letters to name the mutant new coronavirus to avoid stigmatizing the country that first detected and discovered the mutant virus.
-
Eli Lilly reproduces changes!
Time of Update: 2021-06-04
Zhu Ning, vice president of Eli Lilly China's cross-biochemical product division, decided to leave the company to pursue external career development opportunities.
In May 2020, he extended his leadership responsibilities and served as the vice president of Eli Lilly China's cross-biochemical products business unit.
-
Health Commission: 24 new confirmed cases, of which 10 are from the mainland
Time of Update: 2021-06-04
As of 24:00 on June 1, according to reports from 31 provinces (autonomous regions and municipalities) and the Xinjiang Production and Construction Corps, there are currently 346 confirmed cases (including 6 severe cases), a total of 86,164 cured and discharged cases, and a total of 4,636 deaths.
-
Half-year medical commercial bribery cases will be notified and included in the credit rating of pharmaceutical companies
Time of Update: 2021-06-04
The National Medical Insurance Administration’s "Notice on Accelerating the Implementation of the Medical Price and Recruitment Credit Evaluation System" clearly mentioned "In accordance with the territorial principle, all provincial-level centralized procurement agencies pay close attention to the judgment documents and administrative penalty decisions published by the courts, taxation, market supervision and other departments of the region, especially the typical cases reported by the media, and promptly inquire and investigate the enterprises involved.
-
The U.S. FDA approves an innovative oral compound drug for the treatment of schizophrenia and bipolar I disorder
Time of Update: 2021-06-04
On June 1, 2021, Alkermes announced that the US FDA has approved its new drug Lybalvi (formerly known as ALKS 3831) for the treatment of adult schizophrenia and bipolar I disorder.
-
Guangdong: Taking multiple measures simultaneously to carry out the publicity and implementation activities of the newly revised "Regulations on the Supervision and Administration of Medical Devices"
Time of Update: 2021-06-04
Regulations and regulations The market supervision bureaus in Zhuhai, Foshan, Jiangmen, Heyuan, Zhaoqing and other places have also carried out various forms of new "Regulations" publicity and implementation training, setting off a new round of enthusiasm for learning the new "Regulations.
-
my country's first child-specific organ transplant immunosuppressant approved for marketing
Time of Update: 2021-06-04
"Dean Chinese Medical Association credits will designate an organ transplant director committee member , First Affiliated Hospital of Xi'an Jiaotong University, kidney disease hospital president Professor XUE said: "The organ allograft rejection is one of the important causes of poor transplantation, transplantation and early The refined and individualized optimized immunosuppressive program for the maintenance phase after transplantation is essential to improve the long-term prognosis of patients and increase the survival rate.
